SoftOx Solutions AS - Asset Resilience Ratio

Latest as of March 2025: 18.73%

SoftOx Solutions AS (SOFTX) has an Asset Resilience Ratio of 18.73% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Nkr22.82 Million
≈ $2.40 Million USD Cash + Short-term Investments

Total Assets

Nkr121.84 Million
≈ $12.82 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how SoftOx Solutions AS's Asset Resilience Ratio has changed over time. Check SoftOx Solutions AS PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down SoftOx Solutions AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SOFTX stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Nkr22.82 Million 18.73%
Short-term Investments Nkr0.00 0%
Total Liquid Assets Nkr22.82 Million 18.73%

Asset Resilience Insights

  • Good Liquidity Position: SoftOx Solutions AS maintains a healthy 18.73% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

SoftOx Solutions AS Industry Peers by Asset Resilience Ratio

Compare SoftOx Solutions AS's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
Biotechnology 43.36%
argenx NV ADR
NASDAQ:ARGX
Biotechnology 10.93%
Bachem Holding AG
SW:BANB
Biotechnology 0.00%
Tubize-Fin
BR:TUB
Biotechnology 0.05%
Beijing Hotgen Biotech Co Ltd
SHG:688068
Biotechnology 20.87%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.12%
INVENTIVA ADS/1 O.N.
F:6IVA
Biotechnology 52.73%
CorMedix Inc
NASDAQ:CRMD
Biotechnology 0.45%

Annual Asset Resilience Ratio for SoftOx Solutions AS (2016–2024)

The table below shows the annual Asset Resilience Ratio data for SoftOx Solutions AS.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 8.68% Nkr10.51 Million
≈ $1.11 Million
Nkr121.14 Million
≈ $12.75 Million
+0.81pp
2023-12-31 7.87% Nkr7.65 Million
≈ $805.24K
Nkr97.24 Million
≈ $10.23 Million
-1.00pp
2022-12-31 8.87% Nkr6.91 Million
≈ $726.82K
Nkr77.83 Million
≈ $8.19 Million
-44.29pp
2021-12-31 53.17% Nkr56.98 Million
≈ $6.00 Million
Nkr107.18 Million
≈ $11.28 Million
+13.31pp
2020-12-31 39.86% Nkr34.80 Million
≈ $3.66 Million
Nkr87.31 Million
≈ $9.19 Million
-32.54pp
2019-12-31 72.40% Nkr76.00 Million
≈ $8.00 Million
Nkr104.96 Million
≈ $11.05 Million
+67.12pp
2018-12-31 5.29% Nkr1.24 Million
≈ $130.12K
Nkr23.39 Million
≈ $2.46 Million
-49.80pp
2017-12-31 55.09% Nkr17.10 Million
≈ $1.80 Million
Nkr31.04 Million
≈ $3.27 Million
+51.68pp
2016-12-31 3.41% Nkr301.99K
≈ $31.78K
Nkr8.86 Million
≈ $932.31K
--
pp = percentage points

About SoftOx Solutions AS

OL:SOFTX Norway Biotechnology
Market Cap
$23.70 Million
Nkr225.18 Million NOK
Market Cap Rank
#24578 Global
#227 in Norway
Share Price
Nkr0.09
Change (1 day)
-2.28%
52-Week Range
Nkr0.05 - Nkr0.16
All Time High
Nkr112.00
About

SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more